Golimumab Subcutaneous and Insulin Glargine (U-100) Vials
Determining the interaction of Golimumab Subcutaneous and Insulin Glargine (U-100) Vials and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: golimumab
Brand name: Simponi, Simponi SmartJect, Simponi Aria
Synonyms: Golimumab
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Golimumab Subcutaneous-Insulin Glargine (U-300) Pens
- Golimumab Subcutaneous-Insulin glargine and lixisenatide
- Golimumab Subcutaneous-Insulin glargine and lixisenatide Subcutaneous
- Golimumab Subcutaneous-Insulin glargine, recombinant Subcutaneous
- Golimumab Subcutaneous-Insulin glulisine
- Golimumab Subcutaneous-Insulin Glulisine (Cartridges and Pens)
- Insulin Glargine (U-100) Vials-GoLYTELY
- Insulin Glargine (U-100) Vials-Gonadorelin
- Insulin Glargine (U-100) Vials-Gonadorelin Intravenous, Injection
- Insulin Glargine (U-100) Vials-Gonadotropin, Chorionic
- Insulin Glargine (U-100) Vials-Gonal-F
- Insulin Glargine (U-100) Vials-Gonal-f RFF